A UK patient has become the first in Europe to be implanted with the BIOTRONIK’s E-Series pacemaker.
The patient, a woman with a history of heart failure and complete heart block, had an Enitra 8 HF-T QP device implanted on July 27 at Great Western Hospital in Swindon, United Kingdom. The operation was a complete success and she is recovering well.
“The anatomy of this patient and the venous access presented a particular challenge, so the small size of Enitra and the quadripolar left ventricular lead were paramount in the success of the procedure,” explained Dr. Paul Foley, Consultant Cardiologist.
The E-Series has a 14-year expected battery life and an MRI sensor that detects when the device is in an MRI environment and automatically switches it to ProMRI mode. This limits the length of time a device remains in the limited functional state of ProMRI mode to the duration of the MRI scan only. The pacemaker also leaves a less visible mark on the patient’s chest, resulting in improved long-term comfort.
“The small size of Enitra allows for easy handling by physicians, leaves a very good cosmetic result for the patient. Their day-to-day comfort will be noticeably better, too,” said Charlotte Pompei at BIOTRONIK UK.